Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 2
2010 2
2011 2
2012 4
2013 5
2014 5
2015 8
2016 2
2017 7
2018 2
2019 6
2020 4
2021 9
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean xu ning duan (23 results)?
A multicenter study of the clinicopathological characteristics and a risk prediction model of early-stage breast cancer with hormone receptor-positive/human epidermal growth factor receptor 2-low expression.
Xin L, Wu Q, Zhan C, Qin H, Xiang H, Gao M, Duan X, Liu Y, Ye J; Chinese Society of Breast Surgery (CSBrS); Chinese Society of Surgery of Chinese Medical Association. Xin L, et al. Among authors: duan x. Chin Med J (Engl). 2023 Dec 20;136(24):2967-2973. doi: 10.1097/CM9.0000000000002831. Epub 2023 Oct 11. Chin Med J (Engl). 2023. PMID: 37822006 Free PMC article.
Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case-Control Study in Chinese Females.
Li L, Meng X, Liu L, Xiang Y, Wang F, Yu L, Zhou F, Zheng C, Zhou W, Cui S, Tian F, Fan Z, Geng C, Cao X, Yang Z, Wang X, Liang H, Wang S, Jiang H, Duan X, Wang H, Li G, Wang Q, Zhang J, Jin F, Tang J, Li L, Zhu S, Zuo W, Ye C, Yin G, Ma Z, Huang S, Yu Z. Li L, et al. Among authors: duan x. Front Oncol. 2022 Feb 10;12:809570. doi: 10.3389/fonc.2022.809570. eCollection 2022. Front Oncol. 2022. PMID: 35223490 Free PMC article.
Multicenter study of the clinicopathological features and recurrence risk prediction model of early-stage breast cancer with low-positive human epidermal growth factor receptor 2 expression in China (Chinese Society of Breast Surgery 021).
Xin L, Wu Q, Zhan C, Qin H, Xiang H, Xu L, Ye J, Duan X, Liu Y; Chinese Society of Breast Surgery (CSBrS), Chinese Society of Surgery of Chinese Medical Association. Xin L, et al. Among authors: duan x. Chin Med J (Engl). 2022 Mar 20;135(6):697-706. doi: 10.1097/CM9.0000000000002056. Chin Med J (Engl). 2022. PMID: 35274907 Free PMC article.
Neoadjuvant therapy for early human epidermal growth factor receptor 2 positive breast cancer in China: A multicenter real-world study (CSBrS-015).
Cheng Y, Xiang H, Xin L, Duan X, Liu Y; Chinese Society of Breast Surgery (CSBrS), Chinese Society of Surgery of Chinese Medical Association. Cheng Y, et al. Among authors: duan x. Chin Med J (Engl). 2022 Oct 5;135(19):2311-2318. doi: 10.1097/CM9.0000000000002197. Chin Med J (Engl). 2022. PMID: 36535009 Free PMC article.
64 results